Login

Mike Speetzen, CEO of Polaris, joins 'Closing Bell: Overtime' to discuss investor day, earnings, and the state of the high-ticket consumer market. 00:10:00

Share On Facebook Share On Twitter

Marc Murnaghan - Polaris Renewable Energy Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Assessment of Financial Performance and Green Real Estate Strategy | Philippe Rosio , CEO,Fonciere Inea SA.
00:10:00
Trevor Rees-Jones: From Law to Oil & Gas Entrepreneurship
00:10:00
MD/CEO Jordan Kevol discusses latest company announcements in an interview with The Market Herald in Perth, Western Australia.
00:10:00
American Politics and Historical Perspectives: Jaffa on Lincoln's Era|Harry Jaffa
00:10:00
Steven van Rijswijk, CEO of ING, discusses global business and market trends in an interview with CNBC at the World Economic Forum.
00:10:00
From Dropbox to IVP: The CFO Turned VC Investor|Ajay Vashee,General Partner,IVP
00:10:00
Polymetals Resources Partners with Metals Acquisition Ltd for Cobar Basin Expansion | David Sproule, Chairman , Polymetals Resources Ltd.
00:10:00
Ensuring Business Continuity: Commonwealth Financial Network's Approach
00:10:00
Pioneering Lithium Exploration: ION Energy's Journey in Mongolia
00:10:00
Kang Sun of Amprius Technologies and Justin Mirro of Kensington Join Forces in Innovative Partnership | Dr. Kang Sun - Chief Executive Officer of Amprius Technologies
00:10:00
Insights into Oak Hill Advisors' Strategic Approach in Distressed and Private Credit Markets |Glenn August , CEO, Oak Hill Advisors.
00:10:00
Understanding Good Debt vs. Bad Debt: Insights from Kade Hammes | Kade Hammes, Founder, Storybook Financial.

© 2026 Nehu